Works matching DE "VACCINE immunogenicity"
Results: 564
Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 9, p. 317, doi. 10.1007/s40267-023-01010-3
- By:
- Publication type:
- Article
Programmed Catalytic Therapy and Antigen Capture‐Mediated Dendritic Cells Harnessing Cancer Immunotherapies by In Situ‐Forming Adhesive Nanoreservoirs.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 15, p. 1, doi. 10.1002/adfm.202210644
- By:
- Publication type:
- Article
Longitudinal study of antibody response following SARS-CoV-2 vaccination with Pfizer-BioNTech BNT162b2.
- Published in:
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2023, v. 4, n. 3, p. 298, doi. 10.1515/almed-2023-0052
- By:
- Publication type:
- Article
Beyond Needles: Immunomodulatory Hydrogel-Guided Vaccine Delivery Systems.
- Published in:
- Gels (2310-2861), 2025, v. 11, n. 1, p. 7, doi. 10.3390/gels11010007
- By:
- Publication type:
- Article
СТАНДАРТИЗАЦИЯ ИММУНОГЕННОСТИ ИНАКТИВИРОВАННОЙ ВАКЦИНЫ QAZVAC ПРОТИВ КОРОНАВИРУСНОЙ ИНФЕКЦИИ COVID-19 ИЗ ЭПИДЕМИОЛОГИЧЕСКИ АКТУАЛЬНОГО ШТАММА.
- Published in:
- Eurasian Journal of Applied Biotechnology, 2023, n. 4, p. 31
- By:
- Publication type:
- Article
Q Fever Vaccines: Unveiling the Historical Journey and Contemporary Innovations in Vaccine Development.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 151, doi. 10.3390/vaccines13020151
- By:
- Publication type:
- Article
Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 135, doi. 10.3390/vaccines13020135
- By:
- Publication type:
- Article
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 127, doi. 10.3390/vaccines13020127
- By:
- Publication type:
- Article
Vaccines in Dermatology—Present and Future: A Review.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 125, doi. 10.3390/vaccines13020125
- By:
- Publication type:
- Article
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
- By:
- Publication type:
- Article
Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 135, doi. 10.3390/vaccines13020135
- By:
- Publication type:
- Article
Q Fever Vaccines: Unveiling the Historical Journey and Contemporary Innovations in Vaccine Development.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 151, doi. 10.3390/vaccines13020151
- By:
- Publication type:
- Article
Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 127, doi. 10.3390/vaccines13020127
- By:
- Publication type:
- Article
Vaccines in Dermatology—Present and Future: A Review.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 125, doi. 10.3390/vaccines13020125
- By:
- Publication type:
- Article
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
- By:
- Publication type:
- Article
Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 68, doi. 10.3390/vaccines13010068
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 43, doi. 10.3390/vaccines13010043
- By:
- Publication type:
- Article
Enhanced Immunogenicity of Foot-and-Mouth Disease Virus-like Particles Using a Water-in-Oil-in-Water Adjuvant.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 24, doi. 10.3390/vaccines13010024
- By:
- Publication type:
- Article
Newcastle Disease Virus Displaying an Ectodomain of Middle East Respiratory Syndrome Coronavirus Spike Protein Elicited Robust Humoral and Cellular Immunity in Mice.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 2, doi. 10.3390/vaccines13010002
- By:
- Publication type:
- Article
Development, Pre-Clinical Safety, and Immune Profile of RENOVAC—A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1420, doi. 10.3390/vaccines12121420
- By:
- Publication type:
- Article
An Inactivated West Nile Virus Vaccine Candidate Based on the Lineage 2 Strain.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1398, doi. 10.3390/vaccines12121398
- By:
- Publication type:
- Article
The Impact of HIV on B Cell Compartment and Its Implications for COVID-19 Vaccinations in People with HIV.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1372, doi. 10.3390/vaccines12121372
- By:
- Publication type:
- Article
Effects of Baseline Blood Zinc Levels on the Humoral Immune Response After COVID-19 mRNA Vaccination: A Prospective Study in a Japanese Population.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1359, doi. 10.3390/vaccines12121359
- By:
- Publication type:
- Article
A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1356, doi. 10.3390/vaccines12121356
- By:
- Publication type:
- Article
Advances in Vaccine Adjuvants for Teleost Fish: Implications for Aquatic Welfare and the Potential of Nanoparticle-Based Formulations.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1347, doi. 10.3390/vaccines12121347
- By:
- Publication type:
- Article
The Impact of Obesity on Influenza Vaccine Immunogenicity and Antibody Transfer to the Infant During Pregnancy.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1307, doi. 10.3390/vaccines12121307
- By:
- Publication type:
- Article
SARS-CoV-2-Neutralizing Antibodies.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1256, doi. 10.3390/vaccines12111256
- By:
- Publication type:
- Article
Enhanced Humoral and Cellular Immune Responses Elicited by Adenoviral Delivery of SARS-CoV-2 Receptor-Binding Motif Fused to Human Fc.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1247, doi. 10.3390/vaccines12111247
- By:
- Publication type:
- Article
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1241, doi. 10.3390/vaccines12111241
- By:
- Publication type:
- Article
Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1206, doi. 10.3390/vaccines12111206
- By:
- Publication type:
- Article
Immunogenicity and Determinants of Antibody Response to the BNT162b2 mRNA Vaccine: A Longitudinal Study in a Cohort of People Living with HIV.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1172, doi. 10.3390/vaccines12101172
- By:
- Publication type:
- Article
Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1152, doi. 10.3390/vaccines12101152
- By:
- Publication type:
- Article
Enhanced Expression of the L1R Gene of Vaccinia Virus by the tPA Signal Sequence Inserted in a Fowlpox-Based Recombinant Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1115, doi. 10.3390/vaccines12101115
- By:
- Publication type:
- Article
Immunogenicity and Safety of Omicron-Containing Multivalent COVID-19 Vaccines in Unvaccinated and Previously Vaccinated Adults.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1109, doi. 10.3390/vaccines12101109
- By:
- Publication type:
- Article
Evaluation of a Quadrivalent Shigella flexneri Serotype 2a, 3a, 6, and Shigella sonnei O-Specific Polysaccharide and IpaB MAPS Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1091, doi. 10.3390/vaccines12101091
- By:
- Publication type:
- Article
Evaluation of Vaccine Strategies among Healthcare Workers during COVID-19 Omicron Outbreak in Taiwan.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1057, doi. 10.3390/vaccines12091057
- By:
- Publication type:
- Article
Potential Association between Shift Work and Serologic Response to Hepatitis B Vaccination among Manufacturing Workers in Republic of Korea.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1041, doi. 10.3390/vaccines12091041
- By:
- Publication type:
- Article
Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1036, doi. 10.3390/vaccines12091036
- By:
- Publication type:
- Article
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1031, doi. 10.3390/vaccines12091031
- By:
- Publication type:
- Article
Asian Flush Gene Variant Enhances Cellular Immunogenicity of COVID-19 Vaccine: Prospective Observation in the Japanese General Population.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1015, doi. 10.3390/vaccines12091015
- By:
- Publication type:
- Article
Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1001, doi. 10.3390/vaccines12091001
- By:
- Publication type:
- Article
Correction: Cao et al. Effective Functional Immunogenicity of a DNA Vaccine Combination Delivered via In Vivo Electroporation Targeting Malaria Infection and Transmission. Vaccines 2022, 10 , 1134.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Immunogenicity and Safety of Chikungunya Vaccines: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 969, doi. 10.3390/vaccines12090969
- By:
- Publication type:
- Article
Baseline Gut Microbiota Was Associated with Long-Term Immune Response at One Year Following Three Doses of BNT162b2.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 916, doi. 10.3390/vaccines12080916
- By:
- Publication type:
- Article
Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 883, doi. 10.3390/vaccines12080883
- By:
- Publication type:
- Article
Boost and Increased Antibody Breadth Following a Second Dose of PARVAX for SARS-CoV-2 in Mice and Nonhuman Primates.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 882, doi. 10.3390/vaccines12080882
- By:
- Publication type:
- Article
Immunogenicity of an Inactivated Senecavirus A Vaccine with a Contemporary Brazilian Strain in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 845, doi. 10.3390/vaccines12080845
- By:
- Publication type:
- Article
PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 833, doi. 10.3390/vaccines12080833
- By:
- Publication type:
- Article
The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 809, doi. 10.3390/vaccines12070809
- By:
- Publication type:
- Article
Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse Model.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 775, doi. 10.3390/vaccines12070775
- By:
- Publication type:
- Article